Citadel Advisors’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.2K | Buy |
+47,994
| New | +$67.2K | ﹤0.01% | 5394 |
|
|
2024
Q2 | – | Sell |
-13,810
| Closed | -$89.8K | – | 6990 |
|
|
2024
Q1 | $89.8K | Buy |
+13,810
| New | +$89.8K | ﹤0.01% | 5120 |
|
|
2021
Q3 | – | Sell |
-1,511
| Closed | -$38K | – | 7230 |
|
|
2021
Q2 | $38K | Sell |
1,511
-831
| -35% | -$20.9K | ﹤0.01% | 6258 |
|
|
2021
Q1 | $67K | Buy |
+2,342
| New | +$67K | ﹤0.01% | 6023 |
|
|
2020
Q4 | – | Sell |
-2,153
| Closed | -$56K | – | 5694 |
|
|
2020
Q3 | $56K | Buy |
+2,153
| New | +$56K | ﹤0.01% | 4374 |
|
|
2019
Q4 | – | Sell |
-628
| Closed | -$8K | – | 5215 |
|
|
2019
Q3 | $8K | Buy |
+628
| New | +$8K | ﹤0.01% | 4592 |
|
|
2019
Q2 | – | Sell |
-713
| Closed | -$28K | – | 5192 |
|
|
2019
Q1 | $28K | Sell |
713
-313
| -31% | -$12.3K | ﹤0.01% | 4365 |
|
|
2018
Q4 | $17K | Buy |
+1,026
| New | +$17K | ﹤0.01% | 4319 |
|
|
2017
Q3 | – | Sell |
-634
| Closed | -$141K | – | 4205 |
|
|
2017
Q2 | $141K | Buy |
+634
| New | +$141K | ﹤0.01% | 3247 |
|